End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,384 KRW | +9.75% |
|
-33.14% | +134.97% |
2022 | StemLab Inc. announced that it has received KRW 1.5000006 billion in funding | CI |
2022 | StemLab Inc. announced that it expects to receive KRW 1.5000006 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+134.97% | 4.76M | |
+1.43% | 94.45B | |
-1.71% | 38.9B | |
-12.80% | 32.56B | |
-12.28% | 15.98B | |
-0.63% | 13.82B | |
-12.63% | 11.34B | |
+163.45% | 9.81B | |
-53.23% | 9.67B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- A258540 Stock
- News SL Therapeutics, Inc.
- StemLab Inc. announced that it has received KRW 5 billion in funding from DAYLI Partners Co., Ltd., IBK Capital Corporation, Blueotus Co., Ltd., DB Asset Management Co., Ltd.